Literature DB >> 33974423

Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.

Arun K Ghosh1, Jennifer L Mishevich1, Melissa S Jurica2.   

Abstract

Spliceostatins and thailanstatins are intriguing natural products due to their structural features as well as their biological significance. This family of natural products has been the subject of immense synthetic interest because they exhibit very potent cytotoxicity in representative human cancer cell lines. The cytotoxic properties of these natural products are related to their ability to inhibit spliceosomes. FR901564 and spliceostatins have been shown to inhibit spliceosomes by binding to their SF3B component. Structurally, these natural products contain two highly functionalized tetrahydropyran rings with multiple stereogenic centers joined by a diene moiety and an acyclic side chain linked with an amide bond. Total syntheses of this family of natural products led to the development of useful synthetic strategies, which enabled the synthesis of potent derivatives. The spliceosome modulating properties of spliceostatins and synthetic derivatives opened the door for understanding the underlying spliceosome mechanism as well as the development of new therapies based upon small-molecule splicing modulators. This review outlines the total synthesis of spliceostatins, synthetic studies of structural derivatives, and their bioactivity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33974423      PMCID: PMC8919379          DOI: 10.1021/acs.jnatprod.1c00100

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.803


  82 in total

1.  Diphenylprolinol silyl ethers as efficient organocatalysts for the asymmetric Michael reaction of aldehydes and nitroalkenes.

Authors:  Yujiro Hayashi; Hiroaki Gotoh; Takaaki Hayashi; Mitsuru Shoji
Journal:  Angew Chem Int Ed Engl       Date:  2005-07-04       Impact factor: 15.336

2.  Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.

Authors:  Daisuke Kaida; Hajime Motoyoshi; Etsu Tashiro; Takayuki Nojima; Masatoshi Hagiwara; Ken Ishigami; Hidenori Watanabe; Takeshi Kitahara; Tatsuhiko Yoshida; Hidenori Nakajima; Tokio Tani; Sueharu Horinouchi; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

3.  Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.

Authors:  Constantin Cretu; Anant A Agrawal; Andrew Cook; Cindy L Will; Peter Fekkes; Peter G Smith; Reinhard Lührmann; Nicholas Larsen; Silvia Buonamici; Vladimir Pena
Journal:  Mol Cell       Date:  2018-04-12       Impact factor: 17.970

4.  New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action.

Authors:  H Nakajima; Y Hori; H Terano; M Okuhara; T Manda; S Matsumoto; K Shimomura
Journal:  J Antibiot (Tokyo)       Date:  1996-12       Impact factor: 2.649

5.  Total synthesis of microtubule-stabilizing agent (-)-laulimalide.

Authors:  A K Ghosh; Y Wang; J T Kim
Journal:  J Org Chem       Date:  2001-12-28       Impact factor: 4.354

6.  Reactions of alkenylchromium reagents prepared from alkenyl trifluoromethanesulfonates (triflates) with chromium(II) chloride under nickel catalysis.

Authors:  K Takai; M Tagashira; T Kuroda; K Oshima; K Utimoto; H Nozaki
Journal:  J Am Chem Soc       Date:  1986-09-01       Impact factor: 15.419

7.  Asymmetric catalytic alkynylation of acetaldehyde: application to the synthesis of (+)-tetrahydropyrenophorol.

Authors:  Barry M Trost; Adrien Quintard
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-05       Impact factor: 15.336

Review 8.  RNA mis-splicing in disease.

Authors:  Marina M Scotti; Maurice S Swanson
Journal:  Nat Rev Genet       Date:  2015-11-23       Impact factor: 53.242

9.  Nitro-substituted Hoveyda-Grubbs ruthenium carbenes: enhancement of catalyst activity through electronic activation.

Authors:  Anna Michrowska; Robert Bujok; Syuzanna Harutyunyan; Volodymyr Sashuk; Grigory Dolgonos; Karol Grela
Journal:  J Am Chem Soc       Date:  2004-08-04       Impact factor: 15.419

10.  Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Beth E Prichard; Arun K Ghosh; Melissa S Jurica
Journal:  RNA       Date:  2016-01-07       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.